Symptoms:
The sign and symptoms of this infectious disease COVID-19 vary from mild
to severe and at its peak severity where it mainly affects the lungs of
affected person it may leads to death. The symptoms appear after the
incubation period which is the time between exposure and the appearance
of first symptom is about 5.2 days Fernandes and N (2020). The epoch as
of the inception of the COVID-19 symptoms in the direction of death is
from 6- 41 days by means of a norm about 14 days. The onset of symptoms
of the disease and the death period is age dependent and immune status
of the individual got infected. This period is shorter in the persons
above 70 years of age then those under 70 years of age Klein, B et al
(2020). It is significant to memorandum with the intention of the fact
is that there must be some similarity in those of the symptoms flanked
by the COVID-19 infection as well as former betacoronavirus like dry
cough, dyspnea, fever, moreover as bilateral ground-glass opacities as
in the CT scans of the chest Clay, J et al (2020). Conversely, COVID-19
appears to show various exceptional clinical experiences that embrace
those of the affecting the lower airway as obvious by means of the
symptoms of the upper respiratory tract like, sneezing, and rhinorrhoea
along with the painful throat Fang, L et al (2020). Some most frequent
symptoms which are at inception of the COVID-19 infirmity are those as
fever, fatigue as well as cough Tian, S et al (2020), whereas
supplementary symptoms consist of sputum production, haemoptysis,
headache, diarrhea, as well as
lymphopenia. Clinical experience exposed
through the of the chest CT- scan offered as that the pneumonia, though,
as there seems to be some unusual features like those of RNAaemia
Shereen, M et al (2020) acute cardiac injury, acute respiratory syndrome
in addition to occurrence of the grand-glass opacities which is a
leading cause of death. In a number of infected patients, the various
peripheral ground-glass opacities were also seen in those of the sub
pleural areas of the lungs as that
probable initiated both localized as well as systemic type of immune
response so as to cause amplified the inflammation Shi, Y et al (2020).
Unfortunately, in some cases the treatment by means of interferon
inhalation appears to have no clinical consequences moreover it appears
to exacerbate the circumstances by moving ahead to the pulmonary
opacities Bernheim, A et al (2020).
The results from the radiograph of chest also had shown the infiltrate
in the upper lobes of lungs which may results in the occurrence of the
dyspnea as well as hypoxemia Ng, M et al (2020). The patients suffering
from the infection of COVID-19 also developed the GI (gastrointestinal)
symptoms as those of diarrhea and abdominal pain etc. but these GI
symptoms were less likely to be associated with those MERS-COV or
SARS-COV patients Tian, S et al (2020). Consequently, it is imperative
to check fecal as well as urine samples in the direction of to eliminate
an impending substitute means of spread, particularly from the health
care workers as well as patients Lei, S et al (2020). Consequently,
progress of methods to recognize the diverse ways of spread like those
of fecal along with urine samples are immediately defensible for the
development of the ways to inhibit or minimize the transmission and it
will also helpful in the development of therapeutic strategies to
control the disease Zhang, L et al (2020).
Some other symptoms as decrease in oxygen saturation and the coughing
leads the patient to use oxygen or if in serious condition may be the
use ventilator to stable the patient’s condition and the symptoms may
get worse if not treated properly or the person is already suffering
from some other chronic disease as co-morbidity may leads to the chronic
conditions Hu, Z et al (2020).